<DOC>
	<DOCNO>NCT02913716</DOCNO>
	<brief_summary>This study assess mass balance recovery , pharmacokinetics , metabolite profile metabolite identification defactinib .</brief_summary>
	<brief_title>A Phase I , Open-label Study Absorption , Metabolism , Excretion Defactinib ( VS-6063 ) Healthy Male Subjects</brief_title>
	<detailed_description />
	<criteria>Body mass index ( BMI ) 18.0 35.0 kg/m2 History ( Hx ) regular bowel movement Creatinine clearance &gt; 80 mL/min Hx alcohol abuse past 2 yr Current smoker Systolic blood pressure ( S ) diastolic blood pressure ( DBP ) upper limit reference range ( age 4044 &gt; 90/140 ; age 4565 &gt; 90/150 )</criteria>
	<gender>Male</gender>
	<minimum_age>40 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>September 2016</verification_date>
</DOC>